Filter posts

What’s the Buzz?

Meet Deuteria Pharmaceuticals, winner of the 2012 Buzz of BIO competition. What is Buzz of …

We Are BIO

Here’s what the Biotechnology Industry Organization is doing for you. This year, we challenged you …

2012 BIO International Convention: Q&A with Progenika

In anticipation of the 2012 BIO International Convention we spoke with Progenika, a newly established …

International Programming Highlights

For those looking to take advantage of all the Convention has to offer, specifically within …

BIOtech NOW: The Role of Intellectual Property in Global Health

The Role of Intellectual Property in Global Health BIO is committed to increase access to …

PTO Director Kappos Remarks at Innovation Alliance Conference: IP leads to job growth

Thank you Roger [Martin], for that kind introduction.  I would like to thank the Innovation …

BIO's IP Priorities for 2011

As we start a new year, the BIO Intellectual Property Department has determined their 2011 priorities.  …

Is the Myriad Case Decision and/or the DOJ Brief TRIPS Compliant?

Judge Sweet seemed to dismiss Myriad’s constitutional taking and TRIPS claims by indicating: “Finally, Myriad’s suggestion that invalidating …

BIO's Comments on proposed PTO Humanitarian Technologies and Licensing Through the Intellectual Prop...

Here are the highlights from BIO’s recent submission on the proposed PTO “Request for Comments …

Recent Federal Register Notices

 A collection of Federal Register Notices dating back to November 5th.  Mainly for Small and …